200 related articles for article (PubMed ID: 31764175)
21. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
22. Targeting alternative splicing in prostate oncology.
Carling PJ; Elliott DJ; Robson CN; Leung HY; Rajan P
Discov Med; 2009 Aug; 8(41):74-80. PubMed ID: 19788872
[TBL] [Abstract][Full Text] [Related]
23. Diversification of the muscle proteome through alternative splicing.
Nakka K; Ghigna C; Gabellini D; Dilworth FJ
Skelet Muscle; 2018 Mar; 8(1):8. PubMed ID: 29510724
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic targeting of splicing in cancer.
Lee SC; Abdel-Wahab O
Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
[TBL] [Abstract][Full Text] [Related]
25. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
He X; Yuan C; Yang J
Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
[TBL] [Abstract][Full Text] [Related]
26. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
27. Hallmarks of alternative splicing in cancer.
Oltean S; Bates DO
Oncogene; 2014 Nov; 33(46):5311-8. PubMed ID: 24336324
[TBL] [Abstract][Full Text] [Related]
28. Context-dependent functions of KLF4 in cancers: Could alternative splicing isoforms be the key?
Wang L; Shen F; Stroehlein JR; Wei D
Cancer Lett; 2018 Dec; 438():10-16. PubMed ID: 30217565
[TBL] [Abstract][Full Text] [Related]
29. Broad regulation of gene isoform expression by Wnt signaling in cancer.
Idris M; Harmston N; Petretto E; Madan B; Virshup DM
RNA; 2019 Dec; 25(12):1696-1713. PubMed ID: 31506381
[TBL] [Abstract][Full Text] [Related]
30. Identification of transcriptional isoforms associated with survival in cancer patient.
Tang Z; Chen T; Ren X; Zhang Z
J Genet Genomics; 2019 Sep; 46(9):413-421. PubMed ID: 31630971
[TBL] [Abstract][Full Text] [Related]
31. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
Narayanan SP; Singh S; Shukla S
Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
[TBL] [Abstract][Full Text] [Related]
32. Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.
Porter RS; Jaamour F; Iwase S
Mol Cell Neurosci; 2018 Mar; 87():35-45. PubMed ID: 29254826
[TBL] [Abstract][Full Text] [Related]
33. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
34. OncoSplicing: an updated database for clinically relevant alternative splicing in 33 human cancers.
Zhang Y; Yao X; Zhou H; Wu X; Tian J; Zeng J; Yan L; Duan C; Liu H; Li H; Chen K; Hu Z; Ye Z; Xu H
Nucleic Acids Res; 2022 Jan; 50(D1):D1340-D1347. PubMed ID: 34554251
[TBL] [Abstract][Full Text] [Related]
35. Domain-based prediction of the human isoform interactome provides insights into the functional impact of alternative splicing.
Ghadie MA; Lambourne L; Vidal M; Xia Y
PLoS Comput Biol; 2017 Aug; 13(8):e1005717. PubMed ID: 28846689
[TBL] [Abstract][Full Text] [Related]
36. Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.
Bielli P; Pagliarini V; Pieraccioli M; Caggiano C; Sette C
Cells; 2019 Dec; 9(1):. PubMed ID: 31861467
[TBL] [Abstract][Full Text] [Related]
37. Identification of candidates for tumor-specific alternative splicing in the thyroid.
Guimarães GS; Latini FR; Camacho CP; Maciel RM; Dias-Neto E; Cerutti JM
Genes Chromosomes Cancer; 2006 Jun; 45(6):540-53. PubMed ID: 16493598
[TBL] [Abstract][Full Text] [Related]
38. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
39. Physiological and pathological significance of human telomerase reverse transcriptase splice variants.
Bollmann FM
Biochimie; 2013 Nov; 95(11):1965-70. PubMed ID: 23933091
[TBL] [Abstract][Full Text] [Related]
40. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
